EARNINGS PER SHARE - Schedule of Basic and Diluted Earnings (Loss) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 26, 2023
Numerator:
Net income	$ 114,403	$ 39,208	$ 33,929	$ 30,275	$ 153,611	$ 64,204
Denominator:
Weighted average number of common shares outstanding (in shares)	179,807		180,621		180,531	180,293
Effect of dilutive securities (in shares)	1,434		997		1,400	883
Weighted average number of common shares outstanding, diluted (in shares)	181,241		181,618		181,931	181,176
Earnings per common share, basic
Earnings per common share, basic (in dollars per share)	$ 0.64		$ 0.19		$ 0.85	$ 0.36
Earnings per common share, diluted
Earnings per common share, diluted (in dollars per share)	$ 0.63		$ 0.19		$ 0.84	$ 0.35
Amedisys
Earnings per common share, diluted
Business combination, contingent consideration, asset, termination fee	$ 62,800				$ 62,800		$ 106,000